NDC 68788-9410

Etodolac

Etodolac

Etodolac is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is Etodolac.

Product ID68788-9410_334c0a22-9e9c-4bf6-9697-cb35c05e83cd
NDC68788-9410
Product TypeHuman Prescription Drug
Proprietary NameEtodolac
Generic NameEtodolac
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2015-08-18
Marketing CategoryANDA / ANDA
Application NumberANDA076004
Labeler NamePreferred Pharmaceuticals Inc.
Substance NameETODOLAC
Active Ingredient Strength400 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 68788-9410-1

100 TABLET, FILM COATED in 1 BOTTLE (68788-9410-1)
Marketing Start Date2015-08-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-9410-3 [68788941003]

Etodolac TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076004
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-18

NDC 68788-9410-2 [68788941002]

Etodolac TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076004
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-18

NDC 68788-9410-9 [68788941009]

Etodolac TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076004
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-18

NDC 68788-9410-6 [68788941006]

Etodolac TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076004
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-18

NDC 68788-9410-1 [68788941001]

Etodolac TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076004
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-18

Drug Details

Active Ingredients

IngredientStrength
ETODOLAC400 mg/1

OpenFDA Data

SPL SET ID:bf8e9902-f7e4-4e4b-b2bc-62946e15cce5
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197686
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
    • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721

    • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    NDC Crossover Matching brand name "Etodolac" or generic name "Etodolac"

    NDCBrand NameGeneric Name
    0093-0892EtodolacEtodolac
    0093-1118EtodolacEtodolac
    0093-1122EtodolacEtodolac
    0093-1893EtodolacEtodolac
    0093-7172EtodolacEtodolac
    0185-0675EtodolacEtodolac
    0185-0687EtodolacEtodolac
    10544-862EtodolacEtodolac
    16714-497EtodolacEtodolac
    16714-498EtodolacEtodolac
    16714-499EtodolacEtodolac
    21695-049EtodolacEtodolac
    21695-050EtodolacEtodolac
    33261-043EtodolacEtodolac
    33261-044EtodolacEtodolac
    35356-324EtodolacEtodolac
    35356-711EtodolacEtodolac
    35356-826EtodolacEtodolac
    42254-052EtodolacEtodolac
    42254-121Etodolacetodolac
    42291-404EtodolacEtodolac
    42291-405EtodolacEtodolac
    42799-111EtodolacEtodolac
    68151-0738EtodolacEtodolac
    68382-273EtodolacEtodolac
    68382-271EtodolacEtodolac
    68382-272EtodolacEtodolac
    68788-6901EtodolacEtodolac
    68788-9410EtodolacEtodolac
    68788-7315EtodolacEtodolac
    68788-7300EtodolacEtodolac
    68788-7068EtodolacEtodolac
    68788-9928EtodolacEtodolac
    68788-9929EtodolacEtodolac
    68788-9360EtodolacEtodolac
    68788-9990EtodolacEtodolac
    68788-9930EtodolacEtodolac
    69238-1342EtodolacEtodolac
    69238-1343EtodolacEtodolac
    70332-320EtodolacEtodolac
    71335-0092EtodolacEtodolac
    71335-0183EtodolacEtodolac
    71335-0399EtodolacEtodolac
    71335-0602EtodolacEtodolac
    71335-0640EtodolacEtodolac
    71335-0126EtodolacEtodolac
    71335-0982EtodolacEtodolac
    43063-578EtodolacEtodolac
    42799-112EtodolacEtodolac
    43063-671EtodolacEtodolac
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.